January 6th, 2025 (Shanghai) — We are glad to announce that Mr. Christopher Lim, the Chief Financial Officer (CFO) & Chief Business Development Officer (CBDO) of Genixcure, will be presenting at the ACCESS CHINA Partnering Forum @ JPM on January 7th-9th, and 21st-23rd, 2025. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the Western biopharma industry.
About Genixcure
Genixcure is a biotech from S. Korea that develops next-generation AAV vectors leveraged by its proprietary AI system, the InsightMiner. It develops its own AAV gene therapy mainly targeting CNS disorders and pursues global partnerships by which it can make a contribution to a better AAV gene therapy program with the company’s next-generation AAV capsids.
About the speaker
- CSO / Executive Vice President, Fresheasy Co., Ltd.
- Head of Business Development Team, BINEX Co., Ltd.
- Finance & Strategy / M&A, Daewoong Pharmaceutical Co., Ltd.
- Global M&A Team Head, Eland Group
- BA in Management & Economics, Yonsei University
About ACCESS CHINA Partnering Forum
ACCESS CHINA Partnering Forum @ JPM is scheduled to be held on January 7th-9th, and 21st-23rd, 2025, via Zoom webinar. This event helps biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online. During the event, the audience can have access to innovative pharma and healthcare products from worldwide.
Conference Name: ACCESS CHINA Partnering Forum
Date & Time: January 7-9 (Live), and 21-23(VoD), 2025, China time
Content: Keynote Speeches, Panel Discussion, Company Presentations, ChemPartner-ACCESS CHINA Dinner Reception
Scale: Expected 500+ participants Online; 100 company roadshows
Participants: Pharma/Biotech senior management and BDs
View more information at https://biotochina.org/
Contact us:
To register for ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact:
Wendi Xiang
BioToChina.org 